Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver North Intersects 1.83 metres True Width of 1,088 g/t Silver, 3.90 g/t Gold (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Rapport Therapeutics Inc RAPP

Healthcare
Rapport Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is focused on the discovery and development of a portfolio of precision small molecule product candidates. The Company focuses on developing a new class of precision neuromedicines aimed at providing patients with alternatives to existing treatments for central nervous system disorders. It advances a pipeline of... see more

Recent & Breaking News (NDAQ:RAPP)

    Rapport Therapeutics to Present Data at American Epilepsy Society Annual Meeting

    GlobeNewswire 15 hours ago

    Rapport Therapeutics Reports Third Quarter Financials and Provides Business Update

    GlobeNewswire 7 days ago

    Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November

    GlobeNewswire 10 days ago

    Rapport Therapeutics to Present at Upcoming Epilepsy Medical Conferences

    GlobeNewswire September 5, 2024

    Rapport Therapeutics to Present at 22nd Annual Morgan Stanley Global Healthcare Conference and TD Cowen's 4th Annual Novel Mechanisms in Neuropsychiatry Summit

    GlobeNewswire August 29, 2024

    Rapport Therapeutics Reports Second Quarter Financials and Provides Business Update

    GlobeNewswire August 8, 2024

    Rapport Therapeutics to Present Data for TARPγ8 AMPAR Negative Modulator at IASP 2024 World Congress on Pain

    GlobeNewswire July 29, 2024

    Rapport Therapeutics Announces Closing of $174 Million Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares and Concurrent Private Placement

    GlobeNewswire June 12, 2024